EligibleTrials

Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance

Recruiting · NCT06747507 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Nairobi

View the official record on ClinicalTrials.gov →
HIV

Interventions studied

Darunavir+RitonavirDolutegravir Pill

What this trial is about

This clinical trial will address the gap in published data on the effect of dolutegravir (DTG)-associated drug-resistant mutations on viral suppression among people remaining on DTG-based antiretroviral therapy. It will also address the gap in the optimal management strategy for this population.

Who can take part

Age range
3 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

9 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.